DS, R., N, K., BW, D., A, E., & VD, D. (2022). Rifle Blast Exacerbating Hearing Loss in a Patient Treated With Teprotumumab for Thyroid Eye Disease. Ophthalmic plastic and reconstructive surgery, 38(2), e41. https://doi.org/10.1097/IOP.0000000000002078
Chicago Style (17th ed.) CitationDS, Reed, Kostosky N, Davies BW, Epstein A, and Durairaj VD. "Rifle Blast Exacerbating Hearing Loss in a Patient Treated With Teprotumumab for Thyroid Eye Disease." Ophthalmic Plastic and Reconstructive Surgery 38, no. 2 (2022): e41. https://doi.org/10.1097/IOP.0000000000002078.
MLA (9th ed.) CitationDS, Reed, et al. "Rifle Blast Exacerbating Hearing Loss in a Patient Treated With Teprotumumab for Thyroid Eye Disease." Ophthalmic Plastic and Reconstructive Surgery, vol. 38, no. 2, 2022, p. e41, https://doi.org/10.1097/IOP.0000000000002078.